-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, C6AKMm+o6jCLxMUlruuwKf04+Zb7zeWxfJTD14YTq8M1aFClBU/hPHJ86yYpnKH8 tustqYczQFuQJdz3fplR+w== 0000897069-09-001005.txt : 20090610 0000897069-09-001005.hdr.sgml : 20090610 20090610093056 ACCESSION NUMBER: 0000897069-09-001005 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20090608 FILED AS OF DATE: 20090610 DATE AS OF CHANGE: 20090610 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ABOD KENNETH J. CENTRAL INDEX KEY: 0001440250 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10670 FILM NUMBER: 09883428 MAIL ADDRESS: STREET 1: HANGER ORTHOPEDIC GROUP, INC. STREET 2: TWO BETHESDA METRO CENTER, SUITE 1200 CITY: BETHESDA STATE: MD ZIP: 20814 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HANGER ORTHOPEDIC GROUP INC CENTRAL INDEX KEY: 0000722723 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093] IRS NUMBER: 840904275 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: TWO BETHESDA METRO CENTER STREET 2: SUITE 1300 CITY: BETHESDA STATE: MD ZIP: 20814 BUSINESS PHONE: 3019860701 MAIL ADDRESS: STREET 1: TWO BETHESDA METRO CENTER STREET 2: SUITE 1300 CITY: BETHESDA STATE: MD ZIP: 20814 FORMER COMPANY: FORMER CONFORMED NAME: SEQUEL CORP DATE OF NAME CHANGE: 19890814 FORMER COMPANY: FORMER CONFORMED NAME: CELLTECH COMMUNICATIONS INC DATE OF NAME CHANGE: 19860304 4 1 cmw4338_ex.xml X0303 4 2009-06-08 0 0000722723 HANGER ORTHOPEDIC GROUP INC HGR 0001440250 ABOD KENNETH J. HANGER ORTHOPEDIC GROUP, INC. TWO BETHESDA METRO CENTER, SUITE 1200 BETHESDA MD 20814 0 1 0 0 VP, Treas. & Asst. Secretary Common Stock 2009-06-08 4 S 0 875 14.744 D 9625 D These shares were sold at a range of sale prices from $14.77 to $14.7745. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Includes (i) unvested restricted shares which total 2,500 shares of stock from an initial grant of 2,500 shares of restricted stock made on November 13, 2008; and (ii) unvested restricted shares and fully vested shares which total 7,125 shares of stock from an initial grant of 8,000 shares of restricted stock made on June 3, 2008. All remaining unvested restricted shares will continue to vest at a rate of 25% per year of the original grant amount on the anniversary date of the grant. /s/ Teri L. Champ, Attorney-in-Fact 2009-06-10 -----END PRIVACY-ENHANCED MESSAGE-----